SEARCH

SEARCH BY CITATION

References

  • Ahn T. B. and Jeon B. S. (2006) Protective role of heat shock and heat shock protein 70 in lactacystin-induced cell death both in the rat substantia nigra and PC12 cells. Brain Res. 1087, 159167.
  • Arrasate M., Mitra S., Schweitzer E. S., Segal M. R. and Finkbeiner S. (2004) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431, 805810.
  • Auluck P. K., Chan H. Y., Trojanowski J. Q., Lee V. M. and Bonini N. M. (2002) Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson’s disease. Science 295, 865868.
  • Baba M., Nakajo S., Tu P. H., Tomita T., Nakaya K., Lee V. M., Trojanowski J. Q. and Iwatsubo T. (1998) Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson’s disease and dementia with Lewy bodies. Am. J. Pathol. 152, 879884.
  • Bertoncini C. W., Fernandez C. O., Griesinger C., Jovin T. M. and Zweckstetter M. (2005a) Familial mutants of alpha-synuclein with increased neurotoxicity have a destabilized conformation. J. Biol. Chem. 280, 3064930652.
  • Bertoncini C. W., Jung Y. S., Fernandez C. O., Hoyer W., Griesinger C., Jovin T. M. and Zweckstetter M. (2005b) Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein. Proc. Natl Acad. Sci. USA 102, 14301435.
  • Chartier-Harlin M. C., Kachergus J., Roumier C. et al. (2004) Alpha-synuclein locus duplication as a cause of familial Parkinson’s disease. Lancet 364, 11671169.
  • Conway K. A., Lee S. J., Rochet J. C., Ding T. T., Williamson R. E. and Lansbury Jr P. T. (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson’s disease: implications for pathogenesis and therapy. Proc. Natl Acad. Sci. USA 97, 571576.
  • Cuervo A. M., Stefanis L., Fredenburg R., Lansbury P. T. and Sulzer D. (2004) Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305, 12921295.
  • Dedmon M. M., Christodoulou J., Wilson M. R. and Dobson C. M. (2005) Heat shock protein 70 inhibits alpha-synuclein fibril formation via preferential binding to prefibrillar species. J. Biol. Chem. 280, 1473314740.
  • Garcia-Mata R., Bebok Z., Sorscher E. J. and Sztul E. S. (1999) Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera. J. Cell Biol. 146, 12391254.
  • Hasegawa T., Matsuzaki M., Takeda A., Kikuchi A., Akita H., Perry G., Smith M. A. and Itoyama Y. (2004) Accelerated alpha-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells. Brain Res. 1013, 5159.
  • Ibanez P., Bonnet A. M., Debarges B., Lohmann E., Tison F., Pollak P., Agid Y., Durr A. and Brice A. (2004) Causal relation between alpha-synuclein gene duplication and familial Parkinson’s disease. Lancet 364, 11691171.
  • Jiang H., Wu Y. C., Nakamura M., Liang Y., Tanaka Y., Holmes S., Dawson V. L., Dawson T. M., Ross C. A. and Smith W. W. (2006) Parkinson’s disease genetic mutations increase cell susceptibility to stress: Mutant alpha-synuclein enhances H(2)O(2)- and Sin-1-induced cell death. Neurobiol. Aging 28, 17901817.
  • Johnston J. A., Ward C. L. and Kopito R. R. (1998) Aggresomes: a cellular response to misfolded proteins. J. Cell Biol. 143, 18831898.
  • Kayed R., Head E., Sarsoza F. et al. (2007) Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol. Neurodegener. 2, 18.
  • Klucken J., Shin Y., Masliah E., Hyman B. T. and McLean P. J. (2004) Hsp70 Reduces alpha-Synuclein Aggregation and Toxicity. J. Biol. Chem. 279, 2549725502.
  • Kramer M. L. and Schulz-Schaeffer W. J. (2007) Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J. Neurosci. 27, 14051410.
  • Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J. T., Schols L. and Riess O. (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease. Nat. Genet. 18, 106108.
  • Lee H. J. and Lee S. J. (2002) Characterization of cytoplasmic alpha-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells. J. Biol. Chem. 277, 4897648983.
  • Lee M., Hyun D., Halliwell B. and Jenner P. (2001) Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult. J. Neurochem. 76, 9981009.
  • Li W., West N., Colla E. et al. (2005) Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson’s disease-linked mutations. Proc. Natl Acad. Sci. USA 102, 21622167.
  • Liu C. W., Giasson B. I., Lewis K. A., Lee V. M., Demartino G. N. and Thomas P. J. (2005) A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease. J. Biol. Chem. 280, 2267022678.
  • McLean P. J., Kawamata H. and Hyman B. T. (2001) Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons. Neuroscience 104, 901912.
  • McLean P. J., Kawamata H., Shariff S., Hewett J., Sharma N., Ueda K., Breakefield X. O. and Hyman B. T. (2002) TorsinA and heat shock proteins act as molecular chaperones: suppression of alpha-synuclein aggregation. J. Neurochem. 83, 846854.
  • McNaught K. S., Shashidharan P., Perl D. P., Jenner P. and Olanow C. W. (2002) Aggresome-related biogenesis of Lewy bodies. Eur. J. Neurosci. 16, 21362148.
  • Meyer G., Varoqueaux F., Neeb A., Oschlies M. and Brose N. (2004) The complexity of PDZ domain-mediated interactions at glutamatergic synapses: a case study on neuroligin. Neuropharmacology 47, 724733.
  • Polymeropoulos M. H., Lavedan C., Leroy E. et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 276, 20452047.
  • Reina J., Lacroix E., Hobson S. D., Fernandez-Ballester G., Rybin V., Schwab M. S., Serrano L. and Gonzalez C. (2002) Computer-aided design of a PDZ domain to recognize new target sequences. Nat. Struct. Biol. 9, 621627.
  • Roberti M. J., Bertoncini C. W., Klement R., Jares-Erijman E. A. and Jovin T. M. (2007) Fluorescence imaging of amyloid formation in living cells by a functional, tetracysteine-tagged alpha-synuclein. Nat. Methods 4, 345351.
  • Shin Y., Klucken J., Patterson C., Hyman B. T. and McLean P. J. (2005) The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates alpha-synuclein degradation decisions between proteasomal and lysosomal pathways. J. Biol. Chem. 280, 2372723734.
  • Singleton A. B., Farrer M., Johnson J. et al. (2003) alpha-Synuclein locus triplication causes Parkinson’s disease. Science 302, 841.
  • Smith W. W., Margolis R. L., Li X., Troncoso J. C., Lee M. K., Dawson V. L., Dawson T. M., Iwatsubo T. and Ross C. A. (2005) Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells. J. Neurosci. 25, 55445552.
  • Spillantini M. G., Schmidt M. L., Lee V. M., Trojanowski J. Q., Jakes R. and Goedert M. (1997) Alpha-synuclein in Lewy bodies. Nature 388, 839840.
  • Stefanis L., Larsen K. E., Rideout H. J., Sulzer D. and Greene L. A. (2001) Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J. Neurosci. 21, 95499560.
  • Tanaka M., Kim Y. M., Lee G., Junn E., Iwatsubo T. and Mouradian M. M. (2004) Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective. J. Biol. Chem. 279, 46254631.
  • Tofaris G. K., Razzaq A., Ghetti B., Lilley K. S. and Spillantini M. G. (2003) Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function. J. Biol. Chem. 278, 4440544411.
  • Yamamoto A., Lucas J. J. and Hen R. (2000) Reversal of neuropathology and motor dysfunction in a conditional model of Huntington’s disease. Cell 101, 5766.
  • Zarranz J. J., Alegre J., Gomez-Esteban J. C. et al. (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55, 164173.